{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:12:13Z","timestamp":1791231133439,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of Turkey","doi-asserted-by":"publisher","award":["117S149"],"award-info":[{"award-number":["117S149"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ejps.2020.105548","type":"journal-article","created":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T09:53:28Z","timestamp":1599990808000},"page":"105548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Preparation and in vitro \/ in vivo evaluation of flurbiprofen nanosuspension-based gel for dermal application"],"prefix":"10.1016","volume":"155","author":[{"given":"Ayse Nur","family":"Oktay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibel","family":"Ilbasmis-Tamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevtap","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orhan","family":"Uludag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevin","family":"Celebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2020.105548_bib0001","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1590\/s1984-82502016000300015","article-title":"Formulation and evaluation of topical herbal gel for the treatment of arthritis in animal model","volume":"52","author":"Aiyalu","year":"2016","journal-title":"Braz. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105548_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119166","article-title":"Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: preparation, characterization, and in vivo evaluation","author":"Alshweiat","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105548_bib0003","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/gels3020022","article-title":"Cyclodextrin-based nanohydrogels containing polyamidoamine units: a new dexamethasone delivery system for inflammatory diseases","volume":"3","author":"Argenziano","year":"2017","journal-title":"Gels"},{"key":"10.1016\/j.ejps.2020.105548_bib0004","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jconrel.2010.10.005","article-title":"Topical drug delivery by a polymeric nanosphere gel: formulation optimization and in vitro and in vivo skin distribution studies","volume":"149","author":"Batheja","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2020.105548_bib0005","first-page":"194","article-title":"A review on factors affecting the design of nasal drug delivery system","volume":"3","author":"Chand","year":"2011","journal-title":"Int. J. Drug Deliv."},{"key":"10.1016\/j.ejps.2020.105548_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2007.03.025","article-title":"Intranasal delivery: physicochemical and therapeutic aspects","volume":"337","author":"Costantino","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105548_bib0007","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10717540490280697","article-title":"Lipid nano\/submicron emulsions as vehicles for topical flurbiprofen delivery","volume":"11","author":"Fang","year":"2004","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2020.105548_bib0008","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/jphp.12914","article-title":"Analgesic effect of S (+)\u2010flurbiprofen plaster in a rat model of knee arthritis: analysis of gait and synovial fluid prostaglandin E2 levels","volume":"70","author":"Fukumoto","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2020.105548_bib0009","first-page":"302","volume":"5","author":"Gad","year":"2008"},{"key":"10.1016\/j.ejps.2020.105548_bib0010","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s11051-008-9357-4","article-title":"Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system","volume":"10","author":"Gao","year":"2008","journal-title":"J. Nanoparticle Res."},{"key":"10.1016\/j.ejps.2020.105548_bib0011","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1208\/s12249-013-9995-4","article-title":"Influence of critical parameters of nanosuspension formulation on the permeability of a poorly soluble drug through the skin\u2014a case study","volume":"14","author":"Ghosh","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2020.105548_bib0012","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ejps.2012.08.011","article-title":"Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: effect of vitamin E TPGS and nanocrystal particle size on oral absorption","volume":"47","author":"Ghosh","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105548_bib0013","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jps.22271","article-title":"Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen","volume":"100","author":"Gonzalez-Mira","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105548_bib0014","series-title":"Goodman and Gilman's the Pharmacological Basis of Therapeutics","first-page":"638","author":"Goodman","year":"1996"},{"key":"10.1016\/j.ejps.2020.105548_bib0015","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/03639040701833708","article-title":"Investigation of nanostructured lipid carriers for transdermal delivery of flurbiprofen","volume":"34","author":"Han","year":"2008","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2020.105548_bib0016","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijpharm.2012.08.040","article-title":"Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation","volume":"439","author":"Han","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105548_bib0017","doi-asserted-by":"crossref","first-page":"684","DOI":"10.7326\/0003-4819-121-9-199411010-00010","article-title":"The role of leukotrienes in inflammation","volume":"121","author":"Henderson","year":"1994","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejps.2020.105548_bib0018","series-title":"Lippincott's Illustrated Reviews: Pharmacology.","first-page":"110","author":"Howland","year":"2006"},{"key":"10.1016\/j.ejps.2020.105548_bib0019","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/app.35414","article-title":"Improved texture analysis for hydrogel characterization: gel cohesiveness, adhesiveness, and hardness","volume":"125","author":"Hurler","year":"2012","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.ejps.2020.105548_bib0020","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1365-2125.2012.04394.x","article-title":"Flurbiprofen concentration in soft tissues is higher after topical application than after oral administration","volume":"75","author":"Kai","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2020.105548_bib0021","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jddst.2017.12.006","article-title":"Development and characterization of gels and liposomes containing ovalbumin for nasal delivery","volume":"44","author":"Kaplan","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2020.105548_bib0022","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4236\/pp.2012.34056","article-title":"A new in-situ gel formulation of itraconazole for vaginal administration","volume":"3","author":"Karavana","year":"2012","journal-title":"Pharmacol. Pharm."},{"key":"10.1016\/j.ejps.2020.105548_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/9431819","article-title":"Formulation and characterization of potential antifungal oleogel with essential oil of thyme","volume":"2018","author":"Kasparaviciene","year":"2018","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"10.1016\/j.ejps.2020.105548_bib0024","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1248\/bpb.34.1170","article-title":"Prostaglandin E2 and pain\u2014an update","volume":"34","author":"Kawabata","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejps.2020.105548_bib0025","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3109\/03639045.2012.686509","article-title":"Formulation, characterization and in vitro\u2013in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery","volume":"39","author":"Kawadkar","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2020.105548_bib0026","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.chemphyslip.2013.07.010","article-title":"Preparation and evaluation of solid lipid nanoparticles based nanogel for dermal delivery of meloxicam","volume":"175-176","author":"Khurana","year":"2013","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.ejps.2020.105548_bib0027","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/pharmaceutics8020017","article-title":"Nanomilling of drugs for bioavailability enhancement: a holistic formulation-process perspective","volume":"8","author":"Li","year":"2016","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2020.105548_bib0028","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijpharm.2011.03.050","article-title":"Nanosuspensions of poorly soluble drugs: preparation and development by wet milling","volume":"411","author":"Liu","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105548_bib0029","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejpb.2010.12.010","article-title":"Ex vivo skin delivery of diclofenac by transcutol containing liposomes and suggested mechanism of vesicle\u2013skin interaction","volume":"78","author":"Manconi","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2020.105548_bib0030","series-title":"Clarke's Analysis of Drugs and Poisons in Pharmaceuticals, Body Fluids and Postmortem Material","first-page":"50","author":"Moffatt","year":"2004"},{"key":"10.1016\/j.ejps.2020.105548_bib0031","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijpharm.2008.05.031","article-title":"Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes","volume":"361","author":"Mokhtar","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105548_bib0032","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1590\/0001-3765201520130436","article-title":"Physicochemical, in vitro and in vivo evaluation of flurbiprofen microemulsion","volume":"87","author":"Naeem","year":"2015","journal-title":"An. Acad. Bras. Ci\u00eanc."},{"key":"10.1016\/j.ejps.2020.105548_bib0033","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1152\/physrev.1999.79.4.1193","article-title":"Prostanoid receptors: structures, properties, and functions","volume":"79","author":"Narumiya","year":"1999","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejps.2020.105548_bib0034","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/pharmaceutics9040037","article-title":"Topical nano and microemulsions for skin delivery","volume":"9","author":"Nastiti","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2020.105548_bib0035","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1080\/10837450.2019.1667384","article-title":"The effect of critical process parameters of the high pressure homogenization technique on the critical quality attributes of flurbiprofen nanosuspensions","volume":"24","author":"Oktay","year":"2019","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejps.2020.105548_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2020.101690","article-title":"Screening of stabilizing agents to optimize flurbiprofen nanosuspensions using experimental design","author":"Oktay","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2020.105548_bib0037","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejps.2018.07.009","article-title":"Dermal flurbiprofen nanosuspensions: optimization with design of experiment approach and in vitro evaluation","volume":"122","author":"Oktay","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.ejps.2020.105548_bib0038","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1205\/cherd06219","article-title":"Determination of flurbiprofen solubility in a wax-based matrix using hyperdsc, Higuchi release kinetics and microscopy","volume":"85","author":"Oladiran","year":"2007","journal-title":"Chem. Eng. Res. Des."},{"key":"10.1016\/j.ejps.2020.105548_bib0039","doi-asserted-by":"crossref","first-page":"151","DOI":"10.15259\/PCACD.24.014","article-title":"Application of texture profile analysis to investigate the mechanical properties of thermosensitive injectable Chitosan hydrogels","volume":"24","author":"Owczarz","year":"2019","journal-title":"Prog. Chem. Appl. Chitin Deriv."},{"key":"10.1016\/j.ejps.2020.105548_bib0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mimet.2019.04.001","article-title":"Flurbiprofen-loaded ethanolic liposome particles for biomedical applications","volume":"161","author":"Paliwal","year":"2019","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.ejps.2020.105548_bib0041","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12944-019-1064-x","article-title":"Flurbiprofen loaded ethosomes-transdermal delivery of anti-inflammatory effect in rat model","volume":"18","author":"Paliwal","year":"2019","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ejps.2020.105548_bib0042","first-page":"44","article-title":"A detailed review on nociceptive models for the screening of analgesic activity in experimental animals","volume":"2","author":"Patel","year":"2016","journal-title":"Int. J. Neurol. Phys. Ther."},{"key":"10.1016\/j.ejps.2020.105548_bib0043","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/2231-4040.82950","article-title":"Nanosuspension: an approach to enhance solubility of drugs","volume":"2","author":"Patel","year":"2011","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.ejps.2020.105548_bib0044","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4155\/tde.10.16","article-title":"Challenges and opportunities in dermal\/transdermal delivery","volume":"1","author":"Paudel","year":"2010","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejps.2020.105548_bib0045","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.colsurfb.2016.03.026","article-title":"Diclofenac acid nanocrystals as an effective strategy to reduce in vivo skin inflammation by improving dermal drug bioavailability","volume":"143","author":"Pireddu","year":"2016","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.ejps.2020.105548_bib0046","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejps.2015.06.006","article-title":"Novel nanosized formulations of two diclofenac acid polymorphs to improve topical bioavailability","volume":"77","author":"Pireddu","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105548_bib0047","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ijpharm.2017.08.108","article-title":"Dermal miconazole nitrate nanocrystals\u2013formulation development, increased antifungal efficacy & skin penetration","volume":"531","author":"Pyo","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105548_bib0048","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.2147\/DDDT.S140626","article-title":"Aceclofenac nanocrystals with enhanced in vitro, in vivo performance: formulation optimization, characterization, analgesic and acute toxicity studies","volume":"11","author":"Rahim","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejps.2020.105548_bib0049","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jconrel.2016.12.022","article-title":"Topical and cutaneous delivery using nanosystems","volume":"247","author":"Roberts","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2020.105548_bib0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ijpharm.2015.12.019","article-title":"Amorphous cyclosporin A nanoparticles for enhanced dermal bioavailability","volume":"498","author":"Romero","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105548_bib0051","doi-asserted-by":"crossref","first-page":"20713","DOI":"10.1039\/C5RA24516H","article-title":"Aceclofenac\u2013\u03b2-cyclodextrin-vesicles: a dual carrier approach for skin with enhanced stability, efficacy and dermatokinetic profile","volume":"6","author":"Sharma","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejps.2020.105548_bib0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jddst.2017.09.012","article-title":"Nanosuspensions based gel as delivery system of nitrofurazone for enhanced dermal bioavailability","volume":"43","author":"Shen","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2020.105548_bib0053","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2174\/1381612003400533","article-title":"Anti-inflammatory cytokines and cytokine antagonists","volume":"6","author":"Standiford","year":"2000","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejps.2020.105548_bib0054","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/ics.12125","article-title":"Texture analysis of cosmetic\/pharmaceutical raw materials and formulations","volume":"36","author":"Tai","year":"2014","journal-title":"Int. J. Cosmet. Sci."},{"key":"10.1016\/j.ejps.2020.105548_bib0055","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ejps.2014.01.009","article-title":"The biopharmaceutics classification system: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC","volume":"57","author":"Tsume","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105548_bib0056","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1080\/09205063.2015.1082808","article-title":"Preparation and characterization of bioadhesive controlled-release gels of cidofovir for vaginal delivery","volume":"26","author":"Tu\u011fcu-Demir\u00f6z","year":"2015","journal-title":"J. Biomater. Sci., Polym. Ed."},{"key":"10.1016\/j.ejps.2020.105548_bib0057","first-page":"193","article-title":"Nanoparticles for dermal and transdermal drug delivery","volume":"4","author":"Uchechi","year":"2014","journal-title":"Appl. Nanotechnol. Drug Deliv."},{"key":"10.1016\/j.ejps.2020.105548_bib0058","first-page":"64","article-title":"Cellulose-derivatives-based hydrogels as vehicles for dermal and transdermal drug delivery","volume":"2","author":"Vlaia","year":"2016","journal-title":"Emerg. Concepts Anal. Appl. Hydrogels"},{"issue":"1\u20132","key":"10.1016\/j.ejps.2020.105548_bib0059","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijpharm.2014.04.060","article-title":"Nanocrystals of medium soluble actives-Novel concept for improved dermal delivery and production strategy","volume":"470","author":"Zhai","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105548_bib0060","first-page":"205","article-title":"Polymeric nanoparticles\u2010based topical delivery systems for the treatment of dermatological diseases","volume":"5","author":"Zhang","year":"2013","journal-title":"Wiley Interdiscip. Rev."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720303365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720303365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:57:10Z","timestamp":1760529430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098720303365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":60,"alternative-id":["S0928098720303365"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105548","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preparation and in vitro \/ in vivo evaluation of flurbiprofen nanosuspension-based gel for dermal application","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105548","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105548"}}